East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Acetazolamide Tablets USP, 125 mg and 250 mg. Aurobindo Pharma’s Acetazolamide Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Diamox Tablets manufactured by Teva Branded Pharmaceutical Products R&D LLC.

Acetazolamide Tablets are indicated for:

• Adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.